Monosaccharides

3,4-O-Isopropylidene-D-galactal is a modified form of galactal. This compound is a methylated derivative of D-galactal that has been synthesized by the click reaction. It can be used in the synthesis of oligosaccharides and polysaccharides. 3,4-O-Isopropylidene-D-galactal is a high purity compound with a CAS number of 124477-12-9.

3-O-Toluoyl decitabine is a synthetic, high purity drug that is custom synthesized to order. The synthesis of 3-O-Toluoyl decitabine involves the modification of sugar molecules with fluorination, glycosylation, and methylation. This compound has CAS No. 183016-21-9 and is used in the treatment of cancer by inhibiting ribonucleic acid (RNA) synthesis. 3-O-Toluoyl decitabine inhibits RNA polymerase II and III, which are enzymes that catalyze the transcription of DNA into RNA. It also inhibits protein kinase C, which leads to cell death and tumor shrinkage.

Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.

Losartan N1-glucuronide is a glucuronidated metabolite of losartan that is produced naturally in the human body. It is converted from losartan by the enzyme UDP-glucuronosyltransferase, which is found in humans and other animals. The rate of glucuronidation varies between individuals and is determined by genetic factors. Losartan N1-glucuronide has shown to be an effective inhibitor of angiotensin II, with an IC50 value of 1.4 μM. This inhibition can be reversed by dobutamine or recombinant human UGT2B7 enzyme, which are both competitive inhibitors of the enzyme UGT2B7. Magnetic resonance spectroscopy has been used to study the kinetic properties of this inhibitor and its effect on dobutamine-induced changes in cardiac function.

UDP-D-galactosamine disodium salt is a type of sugar that is a substrate for UDP-glucuronosyltransferase (UGT), which catalyzes the transfer of galactose from UDP-D-galactose to other molecules. The product of this reaction is UDP-D-galacturonic acid. It is produced in the liver, where it participates in the synthesis of glycoproteins, glycolipids, and glycosaminoglycans. In addition, it can be found in the distal tubule of the kidney and in leukemia cells. The histological analysis of rat liver tissue showed that UDP-D-galactosamine disodium salt is present in hepatocytes. This sugar also helps with protein synthesis and activates uridine, which can be used as a carbon source. Histological analysis also revealed that UDP-D-galactosamine disodium salt plays an important role in glucose metabolism, as well as

Inhibitor of lysosomal acid β-glucosidase (GlcCerase/glucocerebrosidase) with IC50 in nanomolar range for wildtype and mutant enzyme. It behaves as pharmacological chaperon by binding to instable GlcCerase active site at neutral pH values and facilitating the protein folding. In acidic lysosomes, isofagomine gets release from the enzyme active site. This results in increased levels of functional glucocerebrosidase and brings therapeutic benefits to patients with Gaucher disease.

2,4-O-Ethylidene-D-erythrose is a trimerization product of glyoxal and acetaldehyde. It is an aldehyde that can be used as a precursor to other compounds. The hydrated form of 2,4-O-ethylidene-D-erythrose has been rationalized by the mesoxalic acid and water molecules to form the trimer. This compound can be produced from the glycolaldehyde and sulfoxide in an oxidation reaction with hydrogen peroxide. The acetylation of 2,4-O-ethylidene-D-erythrose produces isoxazolidines which are stereoselective.

Cyanidin-3-O-sophoroside chloride (CAS: 6279-21-6) is a naturally occurring phenolic compound that has been isolated from the roots of Sophora flavescens. This compound is a glycosylated form of protocatechuic acid, which is an organic compound with antioxidant properties. The surface methodology on tissue structure showed that this compound can react with nucleophilic radicals and scavenge free radicals in the presence of chloride ions, which is important for its dietary and medicinal value. COS has also been shown to have anti-inflammatory activities in a model system by inhibiting the production of prostaglandins. COS can be extracted from plants by acidic hydrolysis or preparative high performance liquid chromatography.

1-O-Acetyl-2,3,5-tri-O-benzyl-L-ribofuranose is a modified form of ribofuranose. It is a polymer that contains three or more monosaccharides linked together by glycosidic bonds. It has been modified with methyl groups and fluorine atoms to enhance its properties. This compound can be used in the synthesis of oligosaccharides, which are complex carbohydrates that are not found in nature and have potential applications as drugs.

ADP-4-deoxy-D-glucose is a carbohydrate derivative that has been modified with fluorination. ADP-4 is a methylated, custom synthesized oligosaccharide that contains saccharide and polysaccharide chains. It is not commercially available and must be custom synthesized. The modification of the sugar to ADP-4 involves the addition of one or more atoms of fluorine and may be accomplished by click chemistry. This product has high purity and can be used as a research reagent in the synthesis of complex carbohydrates.